ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,882Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 51

$295K Total Retail Price of All Prescriptions

Rank: 23 out of 51

424 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

10% of this provider’s 424 patients filled at least one prescription for a schedule three drug, compared to an average of 27%.

Risky Drugs to Seniors

2% of this provider’s 6,843 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$33 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 29.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
SIMVASTATIN 582 451 1 4
HYDROCHLOROTHIAZIDE 456 359 2 15
OMEPRAZOLE 418 321 3 3
CARVEDILOL 346 262 4 13
METFORMIN HCL 338 257 5 9
AMLODIPINE BESYLATE 229 194 6 5
FUROSEMIDE 227 165 7 2
LISINOPRIL 216 142 8 7
GLIPIZIDE 216 149 8 40
TRAMADOL HCL 193 137 10 10
ALLOPURINOL 176 139 11 43
LEVOTHYROXINE SODIUM 156 130 12 6
METOPROLOL TARTRATE 151 128 13 14
AZITHROMYCIN 150 115 14 47
HYDROCODONE-ACETAMINOPHEN 141 104 S3 15 1
WARFARIN SODIUM 140 113 16 11
POTASSIUM CHLORIDE 132 104 17 8
LOSARTAN-HYDROCHLOROTHIAZIDE 131 109 18 66
MELOXICAM 127 106 19 20
FAMOTIDINE 106 74 20 55
DOXYCYCLINE HYCLATE 102 76 21 90
PRAVASTATIN SODIUM 94 80 22 19
CYCLOBENZAPRINE HCL 90 40 R 23 53
CLOTRIMAZOLE-BETAMETHASONE 85 61 24 212
DOXAZOSIN MESYLATE 85 85 24 136
ATENOLOL 84 60 26 33
NAMENDA 81 73 27 16
METOPROLOL SUCCINATE 81 65 27 25
GABAPENTIN 80 66 29 12
CRESTOR 73 63 30 46
TRIAMTERENE-HCTZ 71 69 31 80
FLUTICASONE PROPIONATE 66 54 32 51
CELEBREX 65 35 33 129
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 60 33 35
CLONIDINE HCL 62 41 35 26
TAMSULOSIN HCL 62 52 35 36
GEMFIBROZIL 61 39 37 126
AMITRIPTYLINE HCL 59 47 R 38 49
NEXIUM 57 22 39 24
BYSTOLIC 53 53 40 161
DIOVAN 51 44 41 70
CITALOPRAM HBR 51 51 41 18
ZETIA 50 38 43 153
TRAZODONE HCL 50 42 43 23
ZOLPIDEM TARTRATE 50 35 43 22
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 11, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.